Baroreceptors in Blood Pressure Regulation: Acute vs. Chronic Roles

Arterial baroreceptors (carotid sinus, aortic arch) are the primary rapid negative-feedback system for blood pressure (BP) stabilization. Their role differs fundamentally between acute and chronic regulation.

Acute Regulation (Seconds–Hours): The Baroreflex

• Stretch-sensitive mechanoreceptors → glossopharyngeal (IX) / vagus (X) → nucleus tractus solitarius (NTS).
• ↑ BP → ↑ firing → ↑ parasympathetic (vagal) + ↓ sympathetic outflow → ↓ HR, ↓ contractility, vasodilation → BP normalization.
• Response latency: <1 second; gain: ~0.5–1.0 bpm/mmHg (HR), ~3–5 mmHg/mmHg (vascular).
• Resets within 1–2 days to prevailing BP (explains why chronic hypertension is not corrected by baroreflex).

Chronic Regulation (Days–Weeks)

• Baroreceptors do NOT set long-term BP. They reset to defend the current pressure.
• Long-term BP control resides in renal-body fluid system (Guyton): pressure natriuresis → volume homeostasis.
• Sinoaortic denervation (SAD) in animals: initial BP lability, but mean BP returns to baseline within weeks if renal function intact.
• Baroreflex impairment (aging, diabetes, hypertension) → increased BP variability, orthostatic hypotension, but not sustained hypertension per se.

Clinical Implications

• Baroreflex sensitivity (BRS) is a prognostic marker: low BRS → post-MI mortality, sudden cardiac death, heart failure progression.
• Device-based therapy: Baroreflex activation therapy (BAT) for resistant hypertension—modest BP reduction, improves BRS.
• Orthostatic hypotension: Baroreflex failure (neurodegenerative, autoimmune, iatrogenic) → symptomatic drops on standing.

Baroreceptors are the “cruise control” for moment-to-moment BP stability; the kidneys are the “thermostat” for long-term set-point.